Harvard Bioscience
HBIO
HBIO
68 hedge funds and large institutions have $73.2M invested in Harvard Bioscience in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 23
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
68
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$821K | |
| 3 | +$611K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$441K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$344K |
Top Sellers
| 1 | -$1.44M | |
| 2 | -$1.35M | |
| 3 | -$1.02M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$753K |
| 5 |
RA
Royce & Associates
New York
|
-$660K |